FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Topical Drug Product Contact Dermatitis Guide

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance entitled Contact Dermatitis From Topical Drug Products for Cutaneous...

FDA Cosmetic Talc Testing Report

[ Price : $8.95]

FDA posts a final report from an agency-contracted sampling of talc-containing cosmetic products for the presence of asbestos.

Comments on Drug Safety Surveillance Best Practices

[ Price : $8.95]

Federal Register notice: FDA reopens until 5/5 the comment period for a 11/7/2019 notice on Best Practices in Drug and Biological ...

Draft Guide on Including Older Patients in Trials

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance entitled Inclusion of Older Adults in Cancer Clinical Trials.

Policy for Coronavirus Testing Labs

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance entitled Policy for Diagnostics Testing in Laboratories Certified to...

CDER Regulatory Project Management Site Tours

[ Price : $8.95]

Federal Register notice: CDER announces its decision to continue Regulatory Project Management Site Tours and Regulatory Interacti...

Class 1 Recall of 774,000 Alaris Infusion Pumps

[ Price : $8.95]

FDA classifies as Class 1 a Becton Dickinson/CareFusion recall of 774,000 Alaris System infusion pumps and modules due to software...

Justice Dept. Sues SpineFrontier Over Kickbacks

[ Price : $8.95]

The Justice Department files two False Claims Act lawsuits against SpineFrontier and related entities and executives, alleging tha...

Draft Guide on Topical Drug Contact Dermatitis

[ Price : $8.95]

FDA posts a draft guidance on Contact Dermatitis from Topical Drug Products for Cutaneous Application: Human Safety Assessment.

Electrical Stimulation Device Ban

[ Price : $8.95]

Federal Register notice: FDA finalizes a ban on electrical stimulation devices for self-injurious or aggressive behavior.